I will say that I have been very aggressive with the department in terms of pressing the suppliers of approved vaccines to continue to accelerate doses, by which I mean move doses up. Rather than be satisfied with six million doses alone coming to Canada by the end of March, I told the department that we should broaden the negotiations. I said we should be aggressive with suppliers and also branch out to additional sources of supply such as the United States and negotiate for delivery of doses from the U.S., as we saw with the 1.5 million doses coming into Canada from AstraZeneca. I also said with regard to current suppliers—Pfizer and Moderna, for example—that we should be aggressive in pressing them for additional earlier deliveries. Pfizer did come forward and give us 1.5 million additional doses earlier in the quarter.
That's the work we do every day to make sure suppliers are being pressed into earlier and earlier deliveries. As I said, we have moved up 22 million doses to earlier quarters because of that negotiation.